Peer Enhanced Prolonged Exposure

PTSD Clinical Trial

— PEET  

Official title:

Peer Enhanced Exposure Therapy (PEET)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02818114
• Other study ID #: D2188-P
• Status: Completed
• Phase: N/A
• Start date: October 16, 2016
• Est. completion date: October 30, 2018

Study information

• Verified date: June 2019
• Source: VA Office of Research and Development
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators plan to develop and test an intervention using peer specialists (Veterans who have managed PTSD and completed PE) to provide support services for Veterans using prolonged exposure therapy.

Description:

The investigators will use qualitative data from Veterans and PE providers to revise the investigators' manualized intervention for peer support services, then complete a feasibility trial to assess the feasibility and acceptability of Peer Enhanced Prolonged Exposure

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8
• Est. completion date: October 30, 2018
• Est. primary completion date: June 16, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Veteran participants will be individuals appropriate for PE, i.e., :

• Veterans who are currently seeking PE

• meet DSM-5 criteria for PTSD or subthreshold PTSD

• are competent to consent to research

Exclusion Criteria:

• Veteran participants do not have levels of other types of psychopathology that would prevent successful participation in the intervention

Related Conditions & MeSH terms

• PTSD

Intervention

Behavioral:
• Peer Enhanced Prolonged Exposure
Peer support interventions as adjunct to prolonged exposure

Locations

Country	Name	City	State
United States	Minneapolis VA Health Care System, Minneapolis, MN	Minneapolis	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PE Sessions Attended	Number of PE Sessions attended during 10 weeks of participation in study. 10 is the maximum, 0 is the minimum. Higher numbers of sessions attended are an indication of better engagement in treatment.	10 weeks
Primary	Posttraumatic Stress Disorder (PTSD) Checklist-5	Self-report measure of PTSD symptoms; score range is 0-80, with higher scores indicating more PTSD symptoms.	10 weeks